Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M48,797Revenue $M5,770Net Margin (%)6.3Z-Score1.7
Enterprise Value $M64,374EPS $-2.7Operating Margin %20.2F-Score7
P/E(ttm))100.0Cash Flow Per Share $4.9Pre-tax Margin (%)5.4Higher ROA y-yY
Price/Book9.710-y EBITDA Growth Rate %2.9Quick Ratio1.1Cash flow > EarningsY
Price/Sales6.35-y EBITDA Growth Rate %42.8Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow11.8y-y EBITDA Growth Rate %164ROA % (ttm)1.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)10.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M336ROI % (ttm)-4.0Gross Margin Increase y-yY

Gurus Latest Trades with VRX

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXGlenn Greenberg 2014-09-30 Add2.6%$106.73 - $130.26
($118.9)
$ 145.3722%Add 8.86%6,586,582
VRXLou Simpson 2014-09-30 Add1.01%$106.73 - $130.26
($118.9)
$ 145.3722%Add 12.4%1,815,916
VRXWallace Weitz 2014-09-30 Add0.54%$106.73 - $130.26
($118.9)
$ 145.3722%Add 9.05%1,691,525
VRXSteve Mandel 2014-09-30 Add0.46%$106.73 - $130.26
($118.9)
$ 145.3722%Add 8.89%10,985,940
VRXGeorge Soros 2014-09-30 Add0.15%$106.73 - $130.26
($118.9)
$ 145.3722%Add 32.73%626,748
VRXChris Davis 2014-09-30 Add0.15%$106.73 - $130.26
($118.9)
$ 145.3722%Add 11.91%3,529,237
VRXRuane Cunniff 2014-09-30 Add0.14%$106.73 - $130.26
($118.9)
$ 145.3722%Add 0.57%34,494,015
VRXAndreas Halvorsen 2014-09-30 Reduce-1.02%$106.73 - $130.26
($118.9)
$ 145.3722%Reduce -15.75%9,967,690
VRXLee Ainslie 2014-09-30 Reduce-0.18%$106.73 - $130.26
($118.9)
$ 145.3722%Reduce -3.7%2,527,896
VRXJoel Greenblatt 2014-09-30 Sold Out -0.01%$106.73 - $130.26
($118.9)
$ 145.3722%Sold Out0
VRXGlenn Greenberg 2014-06-30 Add2.33%$116.99 - $138.13
($127.6)
$ 145.3714%Add 8.19%6,050,442
VRXAndreas Halvorsen 2014-06-30 Add1.39%$116.99 - $138.13
($127.6)
$ 145.3714%Add 27.27%11,830,932
VRXSteve Mandel 2014-06-30 Add0.64%$116.99 - $138.13
($127.6)
$ 145.3714%Add 14.44%10,089,450
VRXLee Ainslie 2014-06-30 Add0.37%$116.99 - $138.13
($127.6)
$ 145.3714%Add 8.39%2,625,014
VRXGeorge Soros 2014-06-30 Add0.29%$116.99 - $138.13
($127.6)
$ 145.3714%Add 185.46%472,187
VRXChris Davis 2014-06-30 Add0.17%$116.99 - $138.13
($127.6)
$ 145.3714%Add 16.03%3,153,748
VRXJoel Greenblatt 2014-06-30 Buy 0.01%$116.99 - $138.13
($127.6)
$ 145.3714%New holding, 6172 sh.6,172
VRXDaniel Loeb 2014-06-30 Sold Out -0.48%$116.99 - $138.13
($127.6)
$ 145.3714%Sold Out0
VRXJohn Paulson 2014-06-30 Reduce-0.32%$116.99 - $138.13
($127.6)
$ 145.3714%Reduce -49.97%500,300
VRXWallace Weitz 2014-06-30 Reduce-0.19%$116.99 - $138.13
($127.6)
$ 145.3714%Reduce -2.91%1,551,076
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRX George Soros 2014-09-30626,7480.190.61+32.73%
VRX Lou Simpson 2014-09-301,815,9160.549.2+12.4%
VRX Chris Davis 2014-09-303,529,2371.051.4+11.91%
VRX Wallace Weitz 2014-09-301,691,5250.56.5+9.05%
VRX Steve Mandel 2014-09-3010,985,9403.275.6+8.89%
VRX Glenn Greenberg 2014-09-306,586,5821.9632+8.86%
VRX John Paulson 2014-09-30520,7000.160.28+4.08%
VRX Ruane Cunniff 2014-09-3034,494,01510.2824+0.57%
VRX Jeff Ubben 2014-09-3018,923,8775.6416.6
VRX Private Capital 2014-09-30296,8710.094.6-1.19%
VRX Jean-Marie Eveillard 2014-09-301,010,8020.30.33-1.33%
VRX Lee Ainslie 2014-09-302,527,8960.754.8-3.7%
VRX Andreas Halvorsen 2014-09-309,967,6902.975.3-15.75%
VRX Joel Greenblatt 2014-09-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-06-23Sell10,203$121.719.45view
Mirovsky PavelPresident of Valeant Europe 2014-06-02Sell10,000$131.2510.76view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-05-13Sell10,000$130.0811.75view
Provencio Norma AnnDirector 2014-04-01Sell5,000$132.189.98view
Kornwasser LaizerEVP, Company Group Chairman 2014-03-21Buy2,481$134.977.71view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-03-17Sell5,000$141.722.58view
Provencio Norma AnnDirector 2014-03-03Sell5,000$141.622.65view
Provencio Norma AnnDirector 2014-02-03Sell5,000$136.236.71view
Kornwasser LaizerEVP, Company Group Chairman 2014-01-24Buy2,536$132.1510view
Provencio Norma AnnDirector 2014-01-13Sell5,000$1339.3view

Press Releases about VRX :

    Quarterly/Annual Reports about VRX:

    News about VRX:

    Articles On GuruFocus.com
    Wallace Weitz Buys Discovery Communications, Sells Apple in Q3 Nov 14 2014 
    Former Warren Buffett CIO Lou Simpson Buys Liberty Global, Valeant, U.S. Bancorp, Sells TE Connectiv Nov 14 2014 
    Ackman’s Pershing Group Buys Stake in Zoetis Nov 13 2014 
    Valeant Part XIII: channeling Jeff Skilling - or trying to reconstruct Valeant's balance sheet Oct 30 2014 
    Wallace Weitz's Partners Value Fund Q3 2014 Commentary Oct 16 2014 
    Ackman's Pershing Square Now Available To The Public Oct 13 2014 
    Bill Ackman and Valeant Could Sweeten Allergan Deal By $15 A Share Oct 10 2014 
    Wallace Weitz's Value Fund Q2 Commentary Oct 06 2014 
    Transcript of Ruane, Cunniff & Goldfarb Investor Day - May 16, 2014 Oct 05 2014 
    Most Held Canadian Stocks of the Second Quarter Sep 04 2014 


    More From Other Websites
    Business Highlights Nov 21 2014
    Highlights of activist fund JANA Partners’ 3Q 13F Nov 21 2014
    What a week: Botox haze, merger Monday and The Tanned One Nov 21 2014
    After losing out over Allergan, Valeant announces $2 billion buyback Nov 21 2014
    Shire to Relocate Employees Under One Shire Program Nov 20 2014
    Synergy Pharmaceuticals Drug Fares Well in Phase II Study Nov 20 2014
    Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program Nov 20 2014
    Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program Nov 20 2014
    Valeant Pharmaceuticals Announces New $2 Billion Securities Repurchase Program Nov 20 2014
    Valeant Rises After Allergan Snub; Zeltiq In Buy Area Nov 19 2014
    Zoetis Provides 2015 Earnings Guidance Below Estimates Nov 19 2014
    Goldman Hits Motherlode in Deal Making Nov 19 2014
    Zoetis to Buy Abbott's Animal Health Assets for $255 Million Nov 18 2014
    Stocks Hit New Milestones; BitAuto Rebounds Nov 18 2014
    Zoetis 2015 Guidance Misses As Buyout Theories Abound Nov 18 2014
    Actavis: One Day Later, Investors Really Like Allergan Acquisition Nov 18 2014
    Stock Movers: Why 4 Big Drug Stocks Are Rising Today Nov 18 2014
    Profit At Zoetis Will Miss Wall Street's Expectations Next Year Nov 18 2014
    Stocks Hold Near Fresh Milestones; Actavis Hits New High Nov 18 2014
    Ackman Pledges Support For Actavis Bid On Allergan Nov 18 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK